Erratum to: Atypical chronic myeloid leukemia with concomitant CSF3R T618I and SETBP1 mutations unresponsive to the JAK inhibitor ruxolitinib[Annals of Hematology, (2015), DOI:10.1007/s00277-014-2272-0];Atypical chronic myeloid leukemia with concomitant CSF3R T618I and SETBP1 mutations unresponsive to the JAK inhibitor ruxolitinib

Annals of Hematology

Volumn 94, Issue 5, 2015, Pages 879-880

  Ammatuna, Emanuele ^a   Eefting, Matthias ^a   van Lom, Kirsten ^a   Kavelaars, François F ^a   Valk, Peter J M ^a   Touw, Ivo P ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; COLONY STIMULATING FACTOR RECEPTOR; CSF3R PROTEIN, HUMAN; JANUS KINASE; NUCLEAR PROTEIN; PYRAZOLE DERIVATIVE; RUXOLITINIB; SETBP1 PROTEIN, HUMAN;

ANTAGONISTS AND INHIBITORS; CASE REPORT; GENETICS; HUMAN; MALE; MIDDLE AGED; MUTATION;

CARRIER PROTEINS; HUMANS; JANUS KINASES; MALE; MIDDLE AGED; MUTATION; NUCLEAR PROTEINS; PYRAZOLES; RECEPTORS, COLONY-STIMULATING FACTOR;

EID: 84930372114     PISSN: 09395555     EISSN: 14320584     Source Type: Journal    
DOI: 10.1007/s00277-015-2356-5     Document Type: Erratum

References (7)

1. Maxson JE, Gotlib J, Pollyea DA et al (2013) Oncogenic CSF3R mutations in chronic neutrophilic leukemia and atypical CML. N Engl J Med 368:1781–1790
2. Fleischman AG, Maxson JE, Luty SB et al (2013) Blood 122:3628–3631
3. Piazza R, Valletta S, Winkelmann N et al (2013) Recurrent SETBP1 mutations in atypical chronic myeloid leukemia. Nat Genet 45:18–24
4. Lasho TL, Mims A, Elliott MA et al (2014) Chronic neutrophilic leukemia with concurrent CSF3R and SETBP1 mutations: single colony clonality studies, in vitro sensitivity to JAK inhibitors and lack of treatment response to ruxolitinib. Leukemia 28:1363–1365
5. Dao KH, Solti MB, Maxson JE et al (2014) Significant clinical response to JAK1/2 inhibition in a patient with CSF3R-T618I-positive atypical chronic myeloid leukemia. Leukemia Res Rep 3:67–69
6. Pardanani A, Lasho TL, Laborde RR et al (2013) CSF3RT618I is a highly prevalent and specific mutation in chronic neutrophilic leukemia. Leukemia 27:1870–1873
7. Wang SA, Hasserjian RP, Fox PS et al (2014) Atypical chronic myeloid leukemia is clinically distinct from unclassifiable myelodysplastic/myeloproliferative neoplasms. Blood 123:2645–2651